studio lsd has voluntarily closed its trading window for dealing in the company's securities, effective from July 1, 2026. The closure will remain in force until 48 hours after the Board Meeting for the quarter ended June 30, 2026. This decision was taken by the Board of Directors in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct for Prevention of Insider Trading.

During this period, all Designated Persons and their immediate relatives are prohibited from dealing in the securities of Studio LSD Limited. The measure aims to ensure compliance with regulatory standards and maintain market integrity ahead of the financial results for the quarter.

The company communicated this decision to the National Stock Exchange of India Limited on June 26, 2026. The filing was signed by Kiran Parmanand Goklani, Company Secretary & Compliance Officer.

Key Details of Trading Window Closure

Studio LSD Limited reported a net loss of ₹100.02 lakh for the financial year ended March 31, 2026, a reversal from the net profit of ₹1,176.61 lakh in the previous year. The company's total revenue for FY26 stood at ₹7,433.05 lakh, down from ₹10,500.70 lakh in FY25, driven primarily by a decrease in revenue from operations to ₹7,211.31 lakh. The financial results were reviewed by the Audit Committee and approved by the Board of Directors in a meeting held on May 30, 2026.

The company's expenses for the year totaled ₹7,509.60 lakh, with the cost of services accounting for ₹6,081.09 lakh. Other expenses increased to ₹1,769.97 lakh from ₹1,958.16 lakh in the prior year. Despite the annual loss, the company reported a profit of ₹249.01 lakh for the half-year ended March 31, 2026. Earnings per share (EPS) for the year was negative at ₹0.21, compared to a positive EPS of ₹2.88 in FY25.

Financial Performance

The statement of standalone financial results highlighted a contraction in both the top and bottom lines. The profit before tax for the year turned negative at ₹76.55 lakh, a stark contrast to the ₹1,577.50 lakh reported in the previous year. The tax expense for the year was significantly lower at ₹23.47 lakh compared to ₹400.89 lakh in FY25.

IPO Proceeds Utilisation

Studio LSD Limited, which listed on the NSE Emerge platform on August 25, 2025, disclosed the utilisation of its Initial Public Offering (IPO) proceeds. The company raised ₹7,425 lakhs through an IPO of 1,37,50,000 shares at a price of ₹54 per equity share. As of March 31, 2026, the company had utilised ₹28.08 crore of the total proceeds, leaving ₹25.82 crore pending to be utilised.

Board Approvals and Appointments

During the Board meeting, the directors approved the re-appointment of Mr. Parth Shah (DIN: 07990904) as a Director liable to retire by rotation, subject to shareholder approval at the ensuing Annual General Meeting. Mr. Shah, who also serves as the Whole-time Director & CFO, holds 76,38,445 equity shares in the company. Additionally, the Board approved the re-appointment of Mr. S. M. Bhat, Proprietor of M/s. S. M. Bhat & Associates, as the Internal Auditor for the financial year 2026-27, effective May 30, 2026.